首页> 外文OA文献 >TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

【2h】

TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

机译：TOOKAD®可溶性局灶性治疗：两项II期研究的汇总分析，评估局部前列腺癌的微创消融

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A. R. Azzouzi; E. Barret; J. Bennet; C. Moore; S. Taneja; G. Muir; A. Villers; J. Coleman; C. Allen; A. Scherz; M. Emberton;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. TOOKAD (R) Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer [J] . Azzouzi A. R., Barret E., Bennet J., World journal of urology . 2015,第7期

机译：TOOKAD（R）可溶性局灶性治疗：评估局部前列腺癌微创消融的三项II期研究的汇总分析
2. Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad(A (R)) Soluble focal treatment for localized prostate cancer [J] . Lebdai Souhil, Villers Arnaud, Barret Eric, World journal of urology . 2015,第7期

机译：Tookad（A）可溶性局灶性治疗局限性前列腺癌后进行前列腺癌根治术的可行性，安全性和有效性
3. Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy [J] . Moore Caroline M., Azzouzi Abel-Rahmene, Barret Eric, BJU international . 2015,第6期

机译：使用WST11-血管靶向光动力（VTP）治疗方法确定最佳药物剂量和光剂量指数以实现局部前列腺癌的微创灶性消融
4. Vascular-Targeted Photodynamic of Prostate Cancer Phase with Tookad for Recurrent Prostate Cancer Following Radiation Therapy: Initial Clinical Studies [C] . Robert A. Weersink, Brian C. Wilson, Arjen Bogaards, Photonic Therapeutics and Diagnostics III; Progress in Biomedical Optics and Imaging; vol.8 no.1; Proceedings of SPIE-The International Society for Optical Engineering; vol.6424 . 2007

机译：Tookad用于前列腺癌放疗后复发性前列腺癌的血管靶向光动力学研究：初步临床研究
5. Endoglin Regulates Prostate Cancer Invasion through Activin and Bone Morphogenetic Protein Type II Receptors and Interfaces with Beta3 Integrin and Focal Adhesions. [D] . Breen, Michael J. 2013

机译：内皮糖蛋白通过激活素和骨形态发生蛋白II型受体以及与Beta3整合素和局灶性粘连的接口调节前列腺癌的侵袭。
6. TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer [O] . A. R. Azzouzi, E. Barret, J. Bennet, -1

机译：TOOKAD®可溶性局灶性治疗：两项II期研究的综合分析评估局部前列腺癌的微创消融
7. Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials [O] . King Christopher R., Freeman Debra, Kaplan Irving, 2013

机译：立体定向身体放射疗法治疗局限性前列腺癌：来自多机构前瞻性II期临床试验的联合分析
8. Phase I/II Study of Combination Neoadjuvant Hormone Therapy and Weekly OGX-011 (Clusterin Antisense Oligonulceotide) Prior to Radical Prostatectomy in Patients with Localized Prostate Cancer [R] . Chi, K. N. 2008

机译：I / II期研究联合新辅助激素治疗和每周OGX-011（Clusterin反义寡核苷酸）前局部前列腺癌根治性前列腺切除术

TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

著录项

引文网络

相似文献

相关主题

期刊订阅